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Abstract
IMPORTANCE On February 27, 2020, the first patient with coronavirus disease 2019 (COVID-19)
was reported in the Netherlands. During the following weeks, at 2 Dutch teaching hospitals, 9 health
care workers (HCWs) received a diagnosis of COVID-19, 8 of whom had no history of travel to China
or northern Italy, raising the question of whether undetected community circulation was occurring.
OBJECTIVE To determine the prevalence and clinical presentation of COVID-19 among HCWswith
self-reported fever or respiratory symptoms.
DESIGN, SETTING, AND PARTICIPANTS This cross-sectional study was performed in 2 teaching
hospitals in the southern part of the Netherlands in March 2020, during the early phase of the
COVID-19 pandemic. Health care workers employed in the participating hospitals who experienced
fever or respiratory symptoms were asked to voluntarily participate in a screening for infection with
the severe acute respiratory syndrome coronavirus 2. Data analysis was performed inMarch 2020.
MAINOUTCOMESANDMEASURES The prevalence of severe acute respiratory syndrome
coronavirus 2 infection was determined by semiquantitative real-time reverse transcriptase–
polymerase chain reaction on oropharyngeal samples. Structured interviews were conducted to
document symptoms for all HCWswith confirmed COVID-19.
RESULTS Of 9705 HCWs employed (1722male [18%]), 1353 (14%) reported fever or respiratory
symptoms and were tested. Of those, 86 HCWs (6%) were infected with severe acute respiratory
syndrome coronavirus 2 (median age, 49 years [range, 22-66 years]; 15 [17%]male), representing 1%
of all HCWs employed. Most HCWs experiencedmild disease, and only 46 (53%) reported fever.
Eighty HCWs (93%)met a case definition of fever and/or coughing and/or shortness of breath. Only
3 (3%) of the HCWs identified through the screening had a history of travel to China or northern Italy,
and 3 (3%) reported having been exposed to an inpatient with a known diagnosis of COVID-19 before
the onset of symptoms.
CONCLUSIONS ANDRELEVANCE Within 2 weeks after the first Dutch case was detected, a
substantial proportion of HCWswith self-reported fever or respiratory symptoms were infected with
severe acute respiratory syndrome coronavirus 2, likely as a result of acquisition of the virus in the
community during the early phase of local spread. The high prevalence of mild clinical presentations,
frequently not including fever, suggests that the currently recommended case definition for
suspected COVID-19 should be used less stringently.
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Introduction
SinceDecember 2019, theworld has been in the grip of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and the disease it causes, coronavirus disease 2019 (COVID-19).1 On
February 27, 2020, the first patientwith COVID-19was detected in theNetherlands, after a trip to
northern Italy between February 18, 2020, and February 21, 2020.2 From then until March 6, 2020,
another 127 COVID-19 caseswere identified in theNetherlands, including 9 health careworkers (HCWs)
in 2 Dutch teaching hospitals in the southern part of the Netherlandswho received a diagnosis of
COVID-19 betweenMarch 2, 2020, andMarch6, 2020. Eight of these 9HCWshad no history of travel to
China or northern Italy, raising the question ofwhether undetected community circulationwas
occurring. Because these findings coincidedwith the seasonal influenza peak3 and because SARS-CoV-2
infection inHCWscould lead toboth sick leave and introductionof thevirus into thehospital, this finding
prompted a demand for testingHCWs. After initial observations of SARS-CoV-2 detection in persons
withmild symptomswhodid notmeet the definition for case finding,1 screening for SARS-CoV-2was
implemented to determine the prevalence and the clinical presentation of COVID-19 amongHCWswith
self-reported fever or respiratory symptoms in these 2 hospitals.
Methods
StudyDesign, Setting, and Population
The study was reviewed by the Ethics Committee Brabant, the Netherlands. The study was judged to
be beyond the scope of theMedical Research Involving Human Subjects Act, and awaiver of written
informed consent was granted. Oral informed consent was obtained from all HCWs for SARS-CoV-2
testing and from SARS-CoV-2–infected HCWs for data collection. Data were deidentified before
analysis. This study follows the Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) reporting guideline.
A cross-sectional study was conducted in 2 teaching hospitals (700-bed Amphia Hospital,
Breda, the Netherlands; 800-bed Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands)
employing 9705 HCWs (Figure 1). Between March 7, 2020, and March 12, 2020, HCWs with self-
reported fever or (mild) respiratory symptoms in the last 10 days were tested voluntarily for SARS-
CoV-2 infection, following the local infection control policy during outbreaks.
Figure 1. Recruitment of Health CareWorkers
9705 Health care workers employed
4500 Amphia Hospital
5205 Elisabeth-TweeSteden Hospital
1353 Reported fever or mild respiratory symptoms (14%)
783 Amphia Hospital (17%)
570 Elisabeth-TweeSteden Hospital (11%)
86 Had a positive SARS-CoV-2 test (6%)
42 Amphia Hospital (5%)
44 Elisabeth-TweeSteden Hospital (8%)
1267 Had a negative SARS-CoV-2 test (94%)
741 Amphia Hospital
526 Elisabeth-TweeSteden Hospital
8352 Did not report fever or mild respiratory symptoms
3717 Amphia Hospital
4635 Elisabeth-TweeSteden Hospital
SARS-CoV-2 indicates severe acute respiratory
syndrome coronavirus 2.
JAMANetworkOpen | InfectiousDiseases Health CareWorkers With Symptoms of Coronavirus Disease 2019 in 2 Dutch Hospitals
JAMA Network Open. 2020;3(5):e209673. doi:10.1001/jamanetworkopen.2020.9673 (Reprinted) May 21, 2020 2/8
Downloaded From: https://jamanetwork.com/ on 06/03/2020
Procedures
A semiquantitative real-time reverse transcriptase–polymerase chain reaction (45 cycles) targeting the
SARS-CoV-2 E-genewith high analytical sensitivity and specificity was performed on self-collected
oropharyngeal samples, as described previously4 and in eAppendix 1 in the Supplement. Structured
interviewswere conducted betweenMarch 12, 2020, andMarch 16, 2020, to document symptoms for
all HCWswith confirmed COVID-19, including thosewho received a diagnosis beforeMarch 7, 2020
(eAppendix 2 in the Supplement). Datawere collectedwith EDCdata collection software version 2020.1
(Castor). Recoverywas defined as beingwithout symptoms formore than 24 hours.
Statistical Analysis
Given the descriptive nature of this study, sample size calculations and analysis for statistical
significance were not performed. Continuous variables were expressed as medians and ranges.
Categorical variables were summarized as counts and percentages. There were nomissing data. All
analyses were performed with SPSS statistical software version 25.0 (IBM Corp). Data analysis was
performed in March 2020.
Results
Of 9705 HCWs employed (1722male [18%]), 1353 (14%) reported fever or respiratory symptoms and
were tested. Of those, 86 HCWs (6%) were infected with SARS-CoV-2, representing 1% of all HCWs
employed (Figure 1). Health care workers with COVID-19 were employed in 52 different hospital
departments, including 36medical wards, and had amedian age of 49 years (range, 22-66 years); 15
(17%) weremale (Table). Most HCWswith COVID-19 experiencedmild disease. Forty-six (53%)
HCWs reported fever during the course of illness, and another 10 (12%) reported a feverish feeling
without having measured their temperature. Eighty HCWs (93%) met a case definition of fever
and/or coughing and/or shortness of breath. Extending this case definition with severe myalgia
and/or general malaise would capture all 86 (100%) HCWs with COVID-19 in this evaluation. Other
frequent symptoms were headache (49 HCWs [57%]), a runny nose (46 HCWs [53%]), a sore throat
(34 HCWs [40%]), chest pain (25 HCWs [29%]), diarrhea (16 HCWs [19%]), and loss of appetite (15
HCWs [17%]). Seven HCWs (8%) indicated that they were already symptomatic before February 27,
2020, the day the first Dutch patient with COVID-19 was diagnosed (Figure 2).
Four HCWs (5%) had recovered by the day of screening and 19 (22%) had recovered by the day
of the interview, with a median duration of illness of 8 days (range, 1-20 days) (Table). Two HCWs
(2%) were admitted to the hospital and did not develop critical disease up to themoment of
reporting. Among HCWswhowere interviewed during the second week of illness, coughing (45
HCWs [82%] vs 21 HCWs [68%]), shortness of breath (27 HCWs [49%] vs 6 HCWs [19%]), general
malaise (44 HCWs [80%] vs 21 HCWs [68%]), loss of appetite (14 HCWs [25%] vs 1 HCW [3%]), and
altered or lost sense of taste (6 HCWs [11%] vs 0 HCWs) were reportedmore frequently compared
with HCWs who were interviewed during the first week of illness. Twenty-one HCWs (24%) had no
patient contact during their work, and only 3 (3%) reported having been exposed to an inpatient
known to have been diagnosedwith COVID-19 before the onset of symptoms. Fifty-four HCWs (63%)
mentioned having worked while being symptomatic. Until March 7, 2020, the first day of the HCW
screening, 9 patients with documented SARS-CoV-2 infection were hospitalized in the Amphia
Hospital and 5 in the Elisabeth-TweeSteden Hospital. Only 3 (3%) of the infected HCWs identified
through our screeningmet the internationally recommended case definition for suspected COVID-19,
which included a history of travel to China or northern Italy.When using the definitionwithout travel
history to capture community transmission, 44 HCWs (51%) still would not have been detected.
Themedian real-time reverse transcriptase–polymerase chain reaction cycle threshold value (ie,
thenumberof cycles atwhich the fluorescenceexceeds the threshold)was27.0 (range, 14.5-38.5).
Within the limited resolution in time since theonset of symptoms, cycle threshold values tended tobe
higher inHCWswhowere tested later in the courseof thedisease (Figure3). Cycle threshold valueswere
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similar forHCWswith andwithout self-reported fever on thedayof testing (median, 25.1 vs 27.6) and for
HCWswith andwithout any self-reported symptomson thedayof testing (median, 27.0vs26.7).
Discussion
Twoweeks after the first Dutch patient with COVID-19 was reported, the prevalence of COVID-19 in
HCWs with self-reported fever or respiratory symptoms in 2 Dutch hospitals in the southern part of
the Netherlands was 6%, representing 1% of all HCWs employed. This unexpected high prevalence
supported the hypothesis of hidden community spread of SARS-CoV-2. Since March 1, 2020, all
patients with fever or respiratory symptoms in both hospitals were routinely tested for SARS-CoV-2,
and until March 7, 2020, only a limited number of SARS-CoV-2–infected patients were documented,
all of whomwere nursed under strict isolation precautions. Almost one-quarter (24%) of SARS-CoV-
2-infectedHCWs had no patient contact at all, and only 3mentioned exposure to an inpatient known
with COVID-19. Although we cannot exclude acquisition from known or unknown SARS-CoV-2–
infected patients or HCWs to have occurred in some instances, hospital acquisition is unlikely to
Table. Demographic Characteristics, Self-Reported Symptoms, and Outcomes of Health CareWorkers
With Confirmed Coronavirus Disease 2019
Characteristic
Health care workers, No. (%)
Overall
(N = 86)
Interview within
7 d of the onset of
symptoms (n = 31)
Interview >7 d
beyond the onset of
symptoms (n = 55)
Demographic characteristics
Male 15 (17) 6 (19) 9 (16)
Age, median (range), y 49 (22-66) 47 (27-66) 49 (22-65)
Profession
Physician 12 (14) 2 (6) 10 (18)
Nurse 24 (28) 9 (29) 15 (27)
Other, direct patient contact 29 (34) 12 (39) 17 (31)
Other, no direct patient contact 21 (24) 8 (26) 13 (24)
Self-reported symptoms
Fevera 46 (53) 20 (65) 26 (47)
Feeling feverish, temperature not measured 10 (12) 1 (3) 9 (16)
Coughing 66 (77) 21 (68) 45 (82)
Shortness of breath 33 (38) 6 (19) 27 (49)
Sore throat 34 (40) 11 (35) 23 (42)
Runny nose 46 (53) 17 (55) 29 (53)
General malaise 65 (76) 21 (68) 44 (80)
Severe myalgia 54 (63) 21 (68) 33 (60)
Headache 49 (57) 18 (58) 31 (56)
Chest pain 25 (29) 9 (29) 16 (29)
Abdominal pain 5 (6) 1 (3) 4 (7)
Diarrhea or loose stools 16 (19) 5 (16) 11 (20)
Loss of appetite or nausea 15 (17) 1 (3) 14 (25)
Altered or lost sense of taste 6 (7) 0 6 (11)
Other 17 (20) 2 (6)b 15 (27)c
Outcomes on the day of the interview
Recovered 19 (22) 8 (26) 11 (20)
Time until recovery for those recovered,
median (range), d
8 (1-20) 5 (1-7) 9 (8-20)
Time until interview for those not recovered,
median (range), d
9 (4-25) 6 (4-7) 12 (8-25)
Time since the positive severe acute respiratory
syndrome coronavirus 2 test, median (range), d
6 (2-11) 4 (2-6) 6 (2-11)
Hospital admission 2 (2) 0 2 (4)
a Fever was defined as a body temperature of 38.0 °C
or higher.
b Other symptoms included painful or burning eyes
and painful joints.
c Other symptoms included hoarseness, itchy nose,
ear pain, sinus pain, painful or burning eyes, syncope,
agitation or palpitation, vomiting, hemoptysis,
constipation, and skin rash.
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explain the vast majority of cases coming frommore than 50 different departments in 2 hospitals.
The low percentage of men among HCWs with COVID-19 (17%) reflects that among the source
population of HCWs in the 2 participating hospitals (18%).
Most HCWs experiencedmild disease compared with the clinical presentation and outcomes
reported for hospitalized patients so far.5,6 Notably, fever or a feverish feeling was frequently not
reported. It is still unknown what a sensitive case definition for early detection of SARS-CoV-2–
infected individuals would be. At the time of the study, the internationally recommended case
definition including a history of travel to China or northern Italy,1 applied for only 3 (3%) of the
infected HCWs identified through our screening. When using the definition without travel history to
capture community transmission, approximately one-half (51%) of HCWs with COVID-19 in our
hospitals still would not have been detected. Sensitive detection of COVID-19 cases in HCWs is crucial
for hospital infection control policy, particularly for those working with vulnerable patients. We,
therefore, suggest adjusting the currently used case definition for suspected COVID-19 in HCWs by
taking fever as 1 of the possible symptoms and not as a required symptom. Further improvement of
the sensitivity of COVID-19 detection in HCWs can be achieved by adding severemyalgia and general
malaise to the case definition. To the best of our knowledge, this report is the first to describe the
prevalence and clinical presentations of COVID-19 among HCWs, whichmay be helpful for others
seeking to identify HCWswith suspected COVID-19 in an outbreak situation.
Figure 2. Date of Onset of Symptoms for 86Health CareWorkers (HCWs)With Confirmed Coronavirus Disease 2019 (COVID-19)
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Figure 3. Cycle Threshold Values for the Semiquantitative Reverse Transcriptase–Polymerase
Chain Reaction (RT-PCR) (E-gene) by the Time Since the Onset of Symptoms
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The cycle threshold value is the number of cycles at
which the fluorescence exceeds the threshold. Open
circles indicate cycle threshold values for health care
workers who had recovered by the day of screening.
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Limitations
This study has several limitations. First, the screening of HCWswas based on the presence of fever or
respiratory symptoms in the last 10 days, and no data were collected for HCWswithout these
symptoms. The observed 1% prevalence in all HCWs is, thus, a minimal estimate. The lack of data for
asymptomatic HCWs also precluded estimates of the sensitivity and specificity of the reported
symptoms. Second, oropharyngeal swabs were used for testing, whichmay have slightly lower
sensitivity than a nasopharyngeal swab.7 Third, only 22% of SARS-CoV-2–infected HCWs had
recovered by the day of the interview, which limits the evaluation of symptoms during the course of
the disease. However, stratification of symptoms by time since the onset of symptoms indicated
that coughing, shortness of breath, general malaise, loss of appetite, and altered or lost sense of taste
were reportedmore frequently during the second week of illness. Fourth, although the heads of
departments and supervisors insisted that HCWs had themselves tested when they had experienced
fever or respiratory symptoms in the 10 days before the screening, testing was voluntary and based
on self-reported symptoms. This may have led to either overreporting or underreporting of specific
symptoms (self-report bias). Overreporting of symptomswould have resulted in the testing ofmore
individuals without SARS-CoV-2 infection and, thus, in underestimation of the prevalence in
symptomatic HCWs. Underreporting of symptoms, on the other hand, would have resulted in less
testing and underestimation of the prevalence of SARS-CoV-2 infection in the overall group of HCWs.
In Dutch hospitals, sick leave has no personal financial consequences. Underreporting is, therefore,
not expected to be substantial in this group of professionals with a high sense of responsibility. In
addition, recall bias is unlikely to have affected the reporting of fever or respiratory symptoms.
Health care workers were not aware of their SARS-CoV-2 infection status at the time of testing, and
the recall period was short (up to 10 days). At the time of the interview, however, participants had
knowledge of their SARS-CoV-2–positive test, and recall bias could thus have influenced the
spectrum of symptoms reported. Prospective studies using diaries and, if possible, documenting
symptoms while masking participants for test results may overcome such bias.
Conclusions
During the containment phase and within 2 weeks after the first Dutch case was detected, a
substantial proportion of HCWswith self-reported fever or respiratory symptoms were infected with
SARS-CoV-2, likely as the result of acquisition of the virus in the community during the early phase
of local spread. This observation confirms the insidious nature of SARS-CoV-2 spread, given the high
prevalence ofmild clinical presentations thatmay go undetected.8 The spectrumofmild symptoms
present in HCWs with COVID-19, frequently not including fever, suggests that the currently
recommended case definition for suspected COVID-19 should be used less stringently.
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